首页> 美国卫生研究院文献>Clinical and Translational Allergy >Atopic dermatitis prevention in children following maternal probiotic supplementation does not appear to be mediated by breast milk TSLP or TGF-β
【2h】

Atopic dermatitis prevention in children following maternal probiotic supplementation does not appear to be mediated by breast milk TSLP or TGF-β

机译:补充母体益生菌后预防儿童特应性皮炎似乎不是由母乳TSLP或TGF-β介导的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe Probiotics in Prevention of Allergy among Children in Trondheim (ProPACT) study, a randomised, placebo controlled trial, demonstrated that maternal supplementation with probiotic milk reduced the incidence of atopic dermatitis (AD) in infancy. The mechanisms behind this effect are incompletely understood and breast milk cytokines have been postulated as possible mediating factors. In this study we aimed to assess whether breast milk TLSP and TGF-β are affected by a maternal probiotic supplementation regime, and their contribution to the preventive effect of this regime on AD in the offspring.
机译:背景特隆赫姆市预防儿童过敏的益生菌(ProPACT)研究是一项随机,安慰剂对照试验,证明母体补充益生菌牛奶可降低婴儿特应性皮炎(AD)的发生率。尚未完全了解这种作用背后的机制,并且已假定母乳细胞因子是可能的中介因子。在这项研究中,我们旨在评估母乳益生菌补充方案是否会影响母乳中的TLSP和TGF-β,以及它们对这种方案对后代AD的预防作用的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号